CCO Infectious Disease Podcast

Q&A on HIV PrEP: Episode 1 on Transgender Individuals and Racial and Ethnic Minority Men Who Have Sex With Men

Episode Summary

Listen as Raphael J. Landovitz, MD, MSc, and Hyman Scott, MD, MPH, address key considerations for PrEP uptake among transgender individuals and racial and ethnic minority men who have sex with men, including addressing myths and misconceptions, prescribing and monitoring considerations, and applying available data to practice.

Episode Notes

In this episode, Raphael J. Landovitz, MD, MSc, and Hyman Scott, MD, MPH, discuss key considerations for PrEP uptake in transgender individuals and racial and ethnic minority men who have sex with men, including: 

• Misconceptions about PrEP eligibility 
• Strategies to improve lab monitoring on PrEP 
• Leveraging patient navigators and clinic staff to expand PrEP access
• Data on PrEP efficacy in key populations (eg, transgender men, people who inject drugs)
• Considerations for prescribing on-demand and same-day PrEP 
• Addressing healthcare professional hesitancy to prescribe PrEP
• US Preventive Services Task Force PrEP guideline updates
• Bundling sexually transmitted infection services with PrEP

Faculty

Raphael J. Landovitz, MD, MSc
Professor of Medicine
Division of Infectious Diseases
David Geffen School of Medicine
University of California, Los Angeles
Director, UCLA Center for Clinical AIDS Co-Director, Center for HIV Identification, Prevention, and Treatment Services 
Los Angeles, California

Hyman Scott, MD
Assistant Clinical Professor
Department of Medicine
University of California, San Francisco
Clinical Research Medical Director
Bridge HIV
San Francisco Department of 
Public Health
San Francisco, California

Link to full program: 
https://bit.ly/3PZGYdR